Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
about
Innovative clinical trial design for pediatric therapeuticsPharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort studyFluconazole loading dose pharmacokinetics and safety in infantsSafety and pharmacokinetics of multiple-dose anidulafungin in infants and neonatesPediatric cardiovascular drug dosing in critically ill children and extracorporeal membrane oxygenationPopulation pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenationClinical pharmacokinetics of vancomycin in the neonate: a reviewClinical Pharmacology Studies in Critically Ill Children.Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazolePharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenationA Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation TherapyA systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.Population Pharmacokinetics and Dose Optimization of Teicoplanin during Venoarterial Extracorporeal Membrane Oxygenation.Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.Population Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Critically Ill Young Children.Determinants of drug absorption in different ECMO circuits.Vancomycin Dosing in Pediatric Extracorporeal Membrane Oxygenation: Potential Impacts of New Technologies.Medication adsorption into contemporary extracorporeal membrane oxygenator circuits.Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.Antifungal Extraction by the Extracorporeal Membrane Oxygenation Circuit.Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics.Optimising drug dosing in patients receiving extracorporeal membrane oxygenation.Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO
P2860
Q24635308-8ED28318-8D40-4D41-BCAE-AF6C0839A4ACQ33826426-5981DDAF-6528-4F20-A0A4-B7D58D194061Q34636783-9C7067C3-E6C5-4855-AA98-E22788C60876Q34807770-CF1310DE-77BE-4440-AEA9-39803AC7E7EEQ35071572-F1F0F5BC-BB77-4C67-A042-00CD1C3CC6F0Q35161181-28039643-6DEA-45DA-AD6E-F939BFDEB7EAQ35826801-F836F451-D0D3-4212-A5A6-E62ADA27F47EQ36104107-742EF825-BB35-4FF8-B4A8-1CD18EDA143CQ36120465-D19D25C1-C609-4DF5-A396-C5B5AA82098DQ36257532-D899400D-F22A-446E-9AE0-5DAEF76DC1B9Q36452379-8BB18EC7-2CCD-481F-AA9F-E3B5A04E259AQ36521993-5BAC743E-60CC-4BBB-A5CC-C118E9651528Q36652824-3F645DBE-4BC8-4DFC-BC1F-4EA95198B7CCQ36928231-0D1B011C-DF61-47E0-AEEB-916F95F3AD20Q37283031-CA614BB7-E355-43C1-8836-3A26372DDA24Q38012111-50B891A3-6889-4689-A940-7849050AFEB8Q38374584-4B4DF454-6D18-44AC-A4B8-C94652EF33ECQ38935160-27D5B5BD-89E0-4668-AD2C-F44F58A2547DQ39675383-91468F2B-AFBF-4997-89D1-5C1B35772C2AQ41455396-026CD18B-6DA1-4CDC-9D24-6CE1636A10B5Q42362818-4D6C8E00-017D-4632-9D09-5E33AE16A630Q42376928-7E7A063A-65A6-4A7E-95BC-D2644F4271F8Q43163797-6632E75C-B915-43AB-AB7D-E16B0F753384Q43215527-5809F479-68EA-45B3-B23C-73CFB4565668Q45069269-EF5D3710-0DA4-4ECD-BA56-D1B81248CBC4Q55145216-32A7FF03-33BE-4D78-8BBF-27C91BF06945Q55393633-2C3408EB-69BC-4D7F-9D37-9B1494E39911Q58783779-37587D11-A9F3-4D1F-9668-73DFB51EFAAA
P2860
Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Pharmacokinetics of vancomycin ...... orporeal membrane oxygenation.
@ast
Pharmacokinetics of vancomycin ...... orporeal membrane oxygenation.
@en
type
label
Pharmacokinetics of vancomycin ...... orporeal membrane oxygenation.
@ast
Pharmacokinetics of vancomycin ...... orporeal membrane oxygenation.
@en
prefLabel
Pharmacokinetics of vancomycin ...... orporeal membrane oxygenation.
@ast
Pharmacokinetics of vancomycin ...... orporeal membrane oxygenation.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of vancomycin ...... corporeal membrane oxygenation
@en
P2093
P2860
P304
P356
10.1128/AAC.40.5.1139
P407
P577
1996-05-01T00:00:00Z